Sanjivani Paranteral is one of the biggest manufacturers of injectables in the country. The company manufactures a range of products including injections, tablets and syrups. The company’s factory holds WHO- GMP certification for its products. Over the years, the company has attained the status of a preferred manufacturer for well-known brands.
Sanjivani Paranteral recently announced that it would launch anti-cancer products in India in association with a European multinational. The Indian market size for these products is estimated to be Rs5bn. The company expects a business of Rs60-70mn in the next year and also expects a growth of 20% in turnover of anti-cancer products every year for the next 5 years.
The company is also expecting major orders from foreign market for these products, particularly from African and Asian countries. At Rs53, the stock is trading at 5.6x 9M FY06 EPS of Rs9.4.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment